The role of cell density and intratumoral heterogeneity in multidrug resistance O Lavi, JM Greene, D Levy, MM Gottesman Cancer research 73 (24), 7168-7175, 2013 | 81 | 2013 |
Mathematical approach to differentiate spontaneous and induced evolution to drug resistance during cancer treatment JM Greene, JL Gevertz, ED Sontag JCO clinical cancer informatics 3, 1-20, 2019 | 77 | 2019 |
An ex vivo platform for the prediction of clinical response in multiple myeloma A Silva, MC Silva, P Sudalagunta, A Distler, T Jacobson, A Collins, ... Cancer research 77 (12), 3336-3351, 2017 | 72 | 2017 |
A novel COVID-19 epidemiological model with explicit susceptible and asymptomatic isolation compartments reveals unexpected consequences of timing social distancing JL Gevertz, JM Greene, CH Sanchez-Tapia, ED Sontag Journal of Theoretical Biology 510, 110539, 2021 | 66 | 2021 |
Method and system for facilitating parts procurement and production planning across an extended supply chain EW Seaman, L Cohn, J Greene, E Lambert, BJ Steele, DJ White US Patent 7,359,874, 2008 | 52 | 2008 |
The impact of cell density and mutations in a model of multidrug resistance in solid tumors J Greene, O Lavi, MM Gottesman, D Levy Bulletin of mathematical biology 76, 627-653, 2014 | 49 | 2014 |
Universal features of epidemic models under social distancing guidelines M Sadeghi, JM Greene, ED Sontag Annual reviews in control 51, 426-440, 2021 | 48 | 2021 |
Modeling intrinsic heterogeneity and growth of cancer cells JM Greene, D Levy, KL Fung, PS Souza, MM Gottesman, O Lavi Journal of theoretical biology 367, 262-277, 2015 | 48 | 2015 |
Translation inhibition and resource balance in the TX-TL cell-free gene expression system VH Nagaraj, JM Greene, AM Sengupta, ED Sontag Synthetic Biology 2 (1), ysx005, 2017 | 34 | 2017 |
Mathematical details on a cancer resistance model JM Greene, C Sanchez-Tapia, ED Sontag Frontiers in Bioengineering and Biotechnology 8, 501, 2020 | 29 | 2020 |
Mathematical modeling reveals that changes to local cell density dynamically modulate baseline variations in cell growth and drug response JM Greene, D Levy, SP Herrada, MM Gottesman, O Lavi Cancer Research 76 (10), 2882-2890, 2016 | 29 | 2016 |
Simplifying the complexity of resistance heterogeneity in metastasis O Lavi, JM Greene, D Levy, MM Gottesman Trends in molecular medicine 20 (3), 129-136, 2014 | 19 | 2014 |
Minimizing the infected peak utilizing a single lockdown: a technical result regarding equal peaks JM Greene, ED Sontag 2022 American Control Conference (ACC), 3640-3647, 2022 | 9 | 2022 |
Storage medium for facilitating parts procurement and production planning across an extended supply chain EW Seaman, L Cohn, J Greene, E Lambert, BJ Steele, DJ White US Patent 7,519,550, 2009 | 9 | 2009 |
Control structures of drug resistance in cancer chemotherapy JM Greene, C Sanchez-Tapia, ED Sontag 2018 IEEE Conference on Decision and Control (CDC), 5195-5200, 2018 | 6 | 2018 |
Modeling optimal reopening strategies for COVID-19 and its variants by keeping infections low and fixing testing capacity M Dalton, P Dougall, FL Amoah Darko, W Annan, E Asante-Asamani, ... PLoS One 17 (11), e0274407, 2022 | 5 | 2022 |
Validation of a mathematical model of cancer incorporating spontaneous and induced evolution to drug resistance JL Gevertz, JM Greene, ED Sontag bioRxiv, 2019.12. 27.889444, 2019 | 4 | 2019 |
Nutzen eines Medikationsplans aus Sicht der Bürger–eine qualitative Befragung B Strauß, HM Seidling, U Wehrmann, J Szecsenyi, WE Haefeli, ... Das Gesundheitswesen 80 (08/09), 700-707, 2018 | 2 | 2018 |
Understanding therapeutic tolerance through a mathematical model of drug-induced resistance ED Sontag, JL Gevertz, J Greene, N Comandante-Lou, S Prosperi bioRxiv, 2024.09. 04.611211, 2024 | 1 | 2024 |
Utilizing logistic regression to compare risk factors in disease modeling with imbalanced data: a case study in vitamin D and cancer incidence M Meysami, V Kumar, MK Pugh, ST Lowery, S Sur, S Mondal, JM Greene Frontiers in Oncology 13, 1227842, 2023 | 1 | 2023 |